BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez, Inc., announced that it has developed two (2) Leptin products for the treatment of Alzheimer’s disease and other cognitive disorders and has contracted with Paragon Bioservices, Inc. for process optimization and GMP manufacturing of one of these products.
